Human Stage Holdings (TSE:321A) EBIT: 円155 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:321A Human Stage Holdings Corp TSE:321A
12 GF Score
Price 円785.00
! 2 Warning Signs
View Full Analysis

What is Human Stage Holdings EBIT?

Human Stage Holdings TSE:321A 12 EBIT is 円155 Mil as of Mar. 2026. GuruFocus rates TSE:321A with a GF Score™ of 12/100. The stock has 2 warning signs investors should review.

Human Stage Holdings's earnings before interest and taxes (EBIT) for the six months ended in Mar. 2026 was 円13 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2026 was 円155 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Human Stage Holdings's annualized ROC % for the quarter that ended in Mar. 2026 was 0.00%. Human Stage Holdings's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 2.53%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Human Stage Holdings's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 21.88%.

Human Stage Holdings  (TSE:321A) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Human Stage Holdings's annualized ROC % for the quarter that ended in Mar. 2026 is calculated as:

ROC % (Q: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Sep. 2025 ) + Invested Capital (Q: Mar. 2026 ))/ count )
=-123.904 * ( 1 - 100% )/( (2979.425 + 2969.58)/ 2 )
=-0/2974.5025
=0.00 %

where

Invested Capital(Q: Sep. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=4071.043 - 424.417 - ( 1432.277 - max(0, 1220.58 - 1887.781+1432.277))
=2979.425

Invested Capital(Q: Mar. 2026 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=3939.507 - 421.163 - ( 1373.893 - max(0, 1258.333 - 1807.097+1373.893))
=2969.58

Note: The Operating Income data used here is two times the semi-annual (Mar. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

Human Stage Holdings's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Sep. 2025  Q: Mar. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=26.648/( ( (1050.047 + max(12.864, 0)) + (1046.173 + max(-3.917, 0)) )/ 2 )
=26.648/( ( 1062.911 + 1046.173 )/ 2 )
=26.648/1054.542
=2.53 %

where Working Capital is:

Working Capital(Q: Sep. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(373.148 + 0 + 82.356) - (424.417 + 0 + 18.223)
=12.864

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(381.707 + 0 + 51.497) - (421.163 + 0 + 15.958)
=-3.917

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Mar. 2026) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Human Stage Holdings's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Mar. 2026 )
=154.755/707.327
=21.88 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Human Stage Holdings EBIT Related Terms

Human Stage Holdings EBIT Historical Data

* Premium members only.

The historical data trend for Human Stage Holdings's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Human Stage Holdings EBIT Chart

Human Stage Holdings Annual Data
Trend Mar24 Mar25 Mar26
EBIT
247.46 75.48 154.76

Human Stage Holdings Semi-Annual Data
Mar24 Sep24 Mar25 Sep25 Mar26
EBIT 0.00 130.26 -54.78 141.43 13.32

TSE:321A vs HON, MMM: EBIT Comparison

For the Conglomerates subindustry, Human Stage Holdings's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Human Stage Holdings EV-to-EBIT vs Conglomerates Industry

For the Conglomerates industry and Industrials sector, Human Stage Holdings's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Human Stage Holdings's EV-to-EBIT falls into.


TSE:321A
12GF Score
Human Stage Holdings Corp TSE:321A
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Human Stage Holdings EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was 円155 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of 円155 Mil mean?
Human Stage Holdings (TSE:321A) has a EBIT of 円155 Mil as of Mar. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Human Stage Holdings.
Is Human Stage Holdings' EBIT too high?
Human Stage Holdings' current EBIT is 円155 Mil. Overall, Human Stage Holdings has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Human Stage Holdings' EBIT compare to HON and MMM?
Human Stage Holdings' EBIT of 円155 Mil can be compared against companies in the Conglomerates industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Conglomerates company?
A good EBIT depends on the Conglomerates industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Human Stage Holdings. Human Stage Holdings's current EBIT is 円155 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Human Stage Holdings stock overvalued right now?
Human Stage Holdings (TSE:321A) has a current EBIT of 円155 Mil. The current EBIT is 円155 Mil. Human Stage Holdings' overall GF Score™ is 12/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Human Stage Holdings (TSE:321A), the current EBIT is 円155 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Human Stage Holdings Business Description

Address 2-3-13 Azuchimachi, Chuo-ku, Osaka, JPN, 541-0052
Human Stage Holdings Corp is engaged in consulting services related to asset management and operation of group subsidiaries engaged in the temporary staffing business and real estate leasing business.
12GF Score

Get the complete analysis for TSE:321A

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円785.00
Price